Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(25%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

75%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Detailed Status

Completed3

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (25.0%)

N/A3 (75.0%)

Trials by Status

recruiting125%

completed375%

Recent Activity

1 active trials

Showing 4 of 4

recruitingnot_applicable

Betamethasone vs Dextrose Injections in Trigger Finger

NCT07681804

completednot_applicable

Ultrasound-Guided Lumbar Facet Joint Injections for Facet-Related Pain: A Randomized Comparison of Saline, Steroid, and 5% Dextrose

NCT07528794

completednot_applicable

Dextrose Prolotherapy Versus LLLT in Treatment of Obstructive Sleep Apnea

NCT06427161

completedphase_1

Effectiveness of Dextrose Injection for Osgood-Schlatter Disease

NCT01300754

Clinical Trials (4)

Showing 4 of 4 trials

NCT07681804Not Applicable

Betamethasone vs Dextrose Injections in Trigger Finger

Recruiting

NCT07528794Not Applicable

Ultrasound-Guided Lumbar Facet Joint Injections for Facet-Related Pain: A Randomized Comparison of Saline, Steroid, and 5% Dextrose

Completed

NCT06427161Not Applicable

Dextrose Prolotherapy Versus LLLT in Treatment of Obstructive Sleep Apnea

Completed

NCT01300754Phase 1

Effectiveness of Dextrose Injection for Osgood-Schlatter Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 4